Gene/Proteome Database (LMPD)
LMPD ID
LMP012393
Gene ID
Species
Rattus norvegicus (Rat)
Gene Name
androgen receptor
Gene Symbol
Synonyms
Tfm; Andr;
Alternate Names
androgen receptor; dihydrotestosterone receptor; nuclear receptor subfamily 3 group C member 4; androgen receptor (Testicular feminization), same as Tfm;
Chromosome
X
Map Location
Xq22-q32
Summary
binds androgens and activates transcription; required for male sexual development [RGD, Feb 2006]
Orthologs
Proteins
androgen receptor | |
---|---|
Refseq ID | NP_036634 |
Protein GI | 6978535 |
UniProt ID | P15207 |
mRNA ID | NM_012502 |
Length | 902 |
MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREAIQNPGPRHPEAASIAPPGACLQQRQETSPRRRRRQQHPEDGSPQAHIRGTTGYLALEEEQQPSQQQSASEGHPESGCLPEPGAATAPGKGLPQQPPAPPDQDDSAAPSTLSLLGPTFPGLSSCSADIKDILSEAGTMQLLQQQQQQQQQQQQQQQQQQQQQQEVISEGSSSVRAREATGAPSSSKDSYLGGNSTISDSAKELCKAVSVSMGLGVEALEHLSPGEQLRGDCMYASLLGGPPAVRPTPCAPLAECKGLSLDEGPGKGTEETAEYSSFKGGYAKGLEGESLGCSGSSEAGSSGTLEIPSSLSLYKSGAVDEAAAYQNRDYYNFPLALSGPPHPPPPTHPHARIKLENPSDYGSAWAAAAAQCRYGDLASLHGGSVAGPSTGSPPATASSSWHTLFTAEEGQLYGPGGGGGSSSPSDAGPVAPYGYTRPPQGLASQEGDFSASEVWYPGGVVNRVPYPSPSCVKSEMGPWMENYSGPYGDMRLDSTRDHVLPIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDCTIDKFRRKNCPSCRLRKCYEAGMTLGARKLKKLGNLKLQEEGENSSAGSPTEDPSQKMTVSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ |
Gene Information
Gene Ontology (GO Annotations)
GO ID | Source | Type | Description |
---|---|---|---|
GO:0030424 | IDA:RGD | C | axon |
GO:0005737 | ISS:UniProtKB | C | cytoplasm |
GO:0030425 | IDA:RGD | C | dendrite |
GO:0000790 | ISS:UniProtKB | C | nuclear chromatin |
GO:0005634 | ISS:UniProtKB | C | nucleus |
GO:0005886 | IEA:Ensembl | C | plasma membrane |
GO:0003677 | TAS:RGD | F | DNA binding |
GO:0005497 | IMP:RGD | F | androgen binding |
GO:0004882 | ISS:UniProtKB | F | androgen receptor activity |
GO:0050681 | IPI:RGD | F | androgen receptor binding |
GO:0008013 | ISS:UniProtKB | F | beta-catenin binding |
GO:0004879 | ISS:BHF-UCL | F | ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0019904 | IPI:RGD | F | protein domain specific binding |
GO:0005102 | IPI:UniProtKB | F | receptor binding |
GO:0043565 | IEA:Ensembl | F | sequence-specific DNA binding |
GO:0003700 | ISS:UniProtKB | F | sequence-specific DNA binding transcription factor activity |
GO:0044212 | ISS:UniProtKB | F | transcription regulatory region DNA binding |
GO:0008270 | IEA:InterPro | F | zinc ion binding |
GO:0033327 | IEA:Ensembl | P | Leydig cell differentiation |
GO:0060520 | IEA:Ensembl | P | activation of prostate induction by androgen receptor signaling pathway |
GO:0030521 | IMP:RGD | P | androgen receptor signaling pathway |
GO:0071383 | IEP:RGD | P | cellular response to steroid hormone stimulus |
GO:0060742 | IEA:Ensembl | P | epithelial cell differentiation involved in prostate gland development |
GO:0003382 | IEA:Ensembl | P | epithelial cell morphogenesis |
GO:0001701 | IEA:Ensembl | P | in utero embryonic development |
GO:0030522 | ISS:BHF-UCL | P | intracellular receptor signaling pathway |
GO:0060599 | IEA:Ensembl | P | lateral sprouting involved in mammary gland duct morphogenesis |
GO:0048808 | IEA:Ensembl | P | male genitalia morphogenesis |
GO:0046661 | IMP:RGD | P | male sex differentiation |
GO:0019102 | IEA:Ensembl | P | male somatic sex determination |
GO:0060749 | IEA:Ensembl | P | mammary gland alveolus development |
GO:0060571 | IEA:Ensembl | P | morphogenesis of an epithelial fold |
GO:0035264 | IEA:Ensembl | P | multicellular organism growth |
GO:0050680 | IEA:Ensembl | P | negative regulation of epithelial cell proliferation |
GO:2001237 | ISS:BHF-UCL | P | negative regulation of extrinsic apoptotic signaling pathway |
GO:0045720 | ISS:UniProtKB | P | negative regulation of integrin biosynthetic process |
GO:0048645 | IEA:Ensembl | P | organ formation |
GO:0043410 | IEA:Ensembl | P | positive regulation of MAPK cascade |
GO:0051092 | ISS:UniProtKB | P | positive regulation of NF-kappaB transcription factor activity |
GO:0008284 | ISS:UniProtKB | P | positive regulation of cell proliferation |
GO:0043568 | IEA:Ensembl | P | positive regulation of insulin-like growth factor receptor signaling pathway |
GO:0033148 | IEA:Ensembl | P | positive regulation of intracellular estrogen receptor signaling pathway |
GO:0042327 | ISS:UniProtKB | P | positive regulation of phosphorylation |
GO:0045944 | ISS:UniProtKB | P | positive regulation of transcription from RNA polymerase II promoter |
GO:0045893 | ISS:UniProtKB | P | positive regulation of transcription, DNA-templated |
GO:0060740 | IEA:Ensembl | P | prostate gland epithelium morphogenesis |
GO:0060736 | IEA:Ensembl | P | prostate gland growth |
GO:0050790 | IEA:Ensembl | P | regulation of catalytic activity |
GO:0048638 | IEA:Ensembl | P | regulation of developmental growth |
GO:0090003 | ISS:UniProtKB | P | regulation of establishment of protein localization to plasma membrane |
GO:0060685 | IEA:Ensembl | P | regulation of prostatic bud formation |
GO:0003073 | IEA:Ensembl | P | regulation of systemic arterial blood pressure |
GO:0032868 | IEP:RGD | P | response to insulin |
GO:0072520 | IEA:Ensembl | P | seminiferous tubule development |
GO:0007338 | IEA:Ensembl | P | single fertilization |
GO:0007283 | IEA:Ensembl | P | spermatogenesis |
GO:0060748 | IEA:Ensembl | P | tertiary branching involved in mammary gland duct morphogenesis |
GO:0006351 | ISS:UniProtKB | P | transcription, DNA-templated |
KEGG Pathway Links
KEGG Pathway ID | Description |
---|---|
ko04114 | Oocyte meiosis |
rno04114 | Oocyte meiosis |
rno05200 | Pathways in cancer |
ko05215 | Prostate cancer |
rno05215 | Prostate cancer |
REACTOME Pathway Links
Domain Information
UniProt Annotations
Entry Information
Comments
Comment Type | Description |
---|---|
Disease | Note=Defects in Ar are a cause of androgen insensitivity. Rats with this syndrome are called testicular feminized (TFM). |
Domain | Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. In the presence of bound steroid the ligand-binding domain interacts with the N-terminal modulating domain, and thereby activates AR transcription factor activity. Agonist binding is required for dimerization and binding to target DNA. The transcription factor activity of the complex formed by ligand-activated AR and DNA is modulated by interactions with coactivator and corepressor proteins. Interaction with RANBP9 is mediated by both the N- terminal domain and the DNA-binding domain. Interaction with EFCAB6/DJBP is mediated by the DNA-binding domain (By similarity) |
Function | Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. Transcription activation is down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3 (By similarity) |
Miscellaneous | In the absence of ligand, steroid hormone receptors are thought to be weakly associated with nuclear components; hormone binding greatly increases receptor affinity. The hormone- receptor complex appears to recognize discrete DNA sequences upstream of transcriptional start sites. |
Miscellaneous | Transcriptional activity is enhanced by binding to RANBP9. |
Ptm | Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required for plasma membrane targeting and for rapid intracellular signaling via ERK and AKT kinases and cAMP generation (By similarity) |
Ptm | Phosphorylated in prostate cancer cells in response to several growth factors including EGF. Phosphorylation is induced by c-Src kinase (CSK). Tyr-517 is one of the major phosphorylation sites and an increase in phosphorylation and Src kinase activity is associated with prostate cancer progression (By similarity). Phosphorylation by TNK2 enhances the DNA-binding and transcriptional activity. Phosphorylation at Ser-61 by CDK9 regulates AR promoter selectivity and cell growth. Phosphorylation by PAK6 leads to AR-mediated transcription inhibition (By similarity) |
Ptm | Sumoylated on Lys-384 (major) and Lys-503 (By similarity). Ubiquitinated. Deubiquitinated by USP26 (By similarity). 'Lys-6' and 'Lys-27'-linked polyubiquitination by RNF6 modulates AR transcriptional activity and specificity (By similarity) |
Similarity | Belongs to the nuclear hormone receptor family. NR3 subfamily |
Similarity | Contains 1 nuclear receptor DNA-binding domain |
Subcellular Location | Nucleus {ECO:0000255|PROSITE- ProRule:PRU00407, ECO:0000269|PubMed:9725910}. Cytoplasm . Note=Predominantly cytoplasmic in unligated form but translocates to the nucleus upon ligand-binding. Can also translocate to the nucleus in unligated form in the presence of GNB2L1 (By similarity) |
Subunit | Binds DNA as a homodimer. Part of a ternary complex containing AR, EFCAB6/DJBP and PARK7. Interacts with HIPK3 and NR0B2 in the presence of androgen. The ligand binding domain interacts with KAT7/HBO1 in the presence of dihydrotestosterone. Interacts with EFCAB6/DJBP, PELP1, PQBP1, RANBP9, RBAK, SPDEF, SRA1, TGFB1I1, ZNF318 and RREB1. Interacts with ZMIZ1/ZIMP10 and ZMIZ2/ZMIP7 which both enhance its transactivation activity. Interacts with SLC30A9 and RAD54L2/ARIP4. Interacts via the ligand-binding domain with LXXLL and FXXLF motifs from NCOA1, NCOA2, NCOA3, NCOA4 and MAGEA11. The AR N-terminal poly-Gln region binds Ran resulting in enhancement of AR-mediated transactivation. Ran-binding decreases as the poly-Gln length increases. Interacts with HIP1 (via coiled coil domain). Interacts (via ligand-binding domain) with TRIM68. Interacts with TNK2. Interacts with USP26. Interacts with RNF6. Interacts (regulated by RNF6 probably through polyubiquitination) with RNF14; regulates AR transcriptional activity. Interacts with PRMT2 and TRIM24. Interacts with GNB2L1/RACK1. Interacts with RANBP10; this interaction enhances dihydrotestosterone-induced AR transcriptional activity. Interacts with PRPF6 in a hormone-independent way; this interaction enhances dihydrotestosterone-induced AR transcriptional activity. Interacts with STK4/MST1. Interacts with ZIPK/DAPK3. Interacts with LPXN. Interacts with MAK. Part of a complex containing AR, MAK and NCOA3. Interacts with CRY1. {ECO:0000269|PubMed:11320241, ECO:0000269|PubMed:12350225, ECO:0000269|PubMed:15037741, ECO:0000269|PubMed:15603938, ECO:0000269|PubMed:17008401, ECO:0000269|PubMed:17181141, ECO:0000269|PubMed:9725910}. |
Tissue Specificity | Highest levels in the seminal vesicle, ventral prostate and coagulating gland with lower levels in the kidney and levator ani muscle. |
Identical and Related Proteins
Unique RefSeq proteins for LMP012393 (as displayed in Record Overview)
Identical Sequences to LMP012393 proteins
Reference | Database | Accession | Length | Protein Name |
---|---|---|---|---|
GI:6978535 | GenBank | ABL23102.1 | 902 | Sequence 21 from patent US 7129078 |
GI:6978535 | GenBank | AED74998.1 | 902 | Sequence 6 from patent US 7910565 |
GI:6978535 | GenBank | AGV97423.1 | 902 | Sequence 6 from patent US 8513210 |
GI:6978535 | pat | WO | 902 | Sequence 4 from Patent WO 8909791 |
Related Sequences to LMP012393 proteins
Reference | Database | Accession | Length | Protein Name |
---|---|---|---|---|
GI:6978535 | GenBank | AAA40733.1 | 902 | androgen receptor [Rattus norvegicus] |
GI:6978535 | pat | WO | 902 | Sequence 4 from Patent WO 8909791 |
GI:6978535 | SwissProt | P15207.1 | 902 | RecName: Full=Androgen receptor; AltName: Full=Dihydrotestosterone receptor; AltName: Full=Nuclear receptor subfamily 3 group C member 4 [Rattus norvegicus] |